![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/13 | |
A61K 31/496 | |||
A61P 25/28 | |||
A61P 25/16 | |||
A61P 25/18 |
(11) | Number of the document | 3458040 |
(13) | Kind of document | T |
(96) | European patent application number | 16766623.9 |
Date of filing the European patent application | 2016-08-03 | |
(97) | Date of publication of the European application | 2019-03-27 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2016/054674 |
Date | 2016-08-03 |
(87) | Number | WO 2017/199072 |
Date | 2017-11-23 |
(30) | Number | Date | Country code |
201641017203 | 2016-05-18 | IN |
(72) |
NIROGI, Ramakrishna, IN
SHINDE, Anil Karbhari, IN
JAYARAJAN, Pradeep, IN
BHYRAPUNENI, Gopinadh, IN
KAMBHAMPATI, Ramasastri, IN
JASTI, Venkateswarlu, IN
|
(73) |
Suven Life Sciences Limited,
5th Floor Serene Chambers Road No. 5 Off Avenue 7 Banjara Hills, Hyderabad, Telangana 500034,
IN
|
(54) | COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST |
COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST |